Circ_0033530 knockdown alleviates lipopolysaccharide-induced acute lung injury model of human lung fibroblasts by miR-1184/TLR4 axis

Author:

Xia Rui,Shan Yanhua,Luo Songyuan,Li Jiancheng,Liu Yongping

Abstract

Abstract Background Circular RNAs (circRNAs) have been reported to be involved in regulating the progression of sepsis and sepsis-associated damage. Herein, this work investigated whether circ_0033530 had roles in the process of septic acute lung injury (sepsis-ALI) and its associated mechanism. Methods Lipopolysaccharide (LPS)-stimulated human lung fibroblasts MRC-5 were used to mimic the cell model of sepsis-ALI in vitro. Levels of genes and proteins were detected by qRT-PCR and western blotting. Functional experiments were conducted using 5-ethynyl-2’-deoxyuridine (EdU) assay, Cell counting Kit-8 (CCK-8) assay, flow cytometry, and Enzyme-Linked Immunosorbent Assay (ELISA), respectively. The interaction between miR-1184 and circ_0033530 or Toll-like receptor 4 (TLR4) was confirmed by dual-luciferase reporter and RNA immunoprecipitation (RIP) assays. Results Circ_0033530 expression was lower in sepsis patients and LSP-induced fibroblasts than those in healthy control and untreated cells. Functionally, knockdown of circ_0033530 protected fibroblasts against LPS-induced proliferation arrest, apoptosis and inflammatory response. Mechanistically, circ_0033530 acted as a sponge for miR-1184, and TLR4 RNA was targeted by miR-1184, indicating the circ_0033530/miR-1184/TLR4 axis. Further rescue experiments showed that circ_0033530 silencing-mediated growth inhibition and inflammation on fibroblasts were attenuated by miR-1184 down-regulation or TLR4 up-regulation. Conclusion Circ_0033530 knockdown alleviated LPS-induced proliferation arrest, apoptosis and inflammation in lung fibroblasts by miR-1184/TLR4 axis, provide molecular theoretical basis for circ_0033530 on the pathogenesis of sepsis-ALI.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Critical Care and Intensive Care Medicine,Emergency Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3